Products

Products

Home page

Intermediates

7,8,9,10-Tetrahydro-8-(trifluoroacetyl)-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine

6,6-Dimethyl-3-azabicyclo[3.1.0]hexane

3-Fluoro-5-hydroxybenzonitrile

[1,2,4]Triazolo[1,5-a]pyridin-7-ol

1H-Indazole-7-carboxylic Acid

N-Tert-butyl-1H-indazole-7-carboxamide

Dimorpholinophosphinyl Chloride

Fmoc-L-glutamicacidgamma-methylester

2-(2-Amino-5-bromobenzoyl)pyridine

4-Methylidenepiperidine, Hydrochloride

1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride

(R)-(+)-1-(1-Naphthyl)ethylamine

N-((R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-propanamide

(R)-(+)-1-Phenylethanol

(S)-(-)-1-Phenylethanol

Pyridine-2-sulfonyl fluoride

< 1 2 3 >

News Center

Precision Diagnostics, Shared Globally | Viwit Ships First U.S. Commercial Batch of Gadobutrol Injection

Viwit President Dr. Keene Wei Shares Global Innovation Strategy at Zaozhuang International Business Services Forum

Viwit’s Gadoterate Meglumine Injection Receives U.S. FDA Approval

Viwit Solid-Dosage Manufacturing Site Successfully Completes Another U.S. FDA cGMP Inspection

Review, Align, and Move Forward — Viwit Successfully Holds 2026 Mid-Year Business Meeting

Viwit’s Application for Consistency Evaluation of Diazepam Injection Accepted by NMPA

← Back to previous page

(R)-(3-Chlorophenyl)oxirane

Product Name:

(R)-(3-Chlorophenyl)oxirane

CAS#:

62600-71-9

VIWIT

Drug and Medical Device Internet Information Service Filing Number: 沪网药信备字〔2025〕00283号 Internet Information Service Filing Number: 沪ICP备12014533号

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search